These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24099410)

  • 1. The activity of circulating dipeptidyl peptidase-4 is associated with subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus.
    Ravassa S; Barba J; Coma-Canella I; Huerta A; López B; González A; Díez J
    Cardiovasc Diabetol; 2013 Oct; 12():143. PubMed ID: 24099410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neurogenic response of cardiac resident nestin(+) cells was associated with GAP43 upregulation and abrogated in a setting of type I diabetes.
    Chabot A; Meus MA; Hertig V; Duquette N; Calderone A
    Cardiovasc Diabetol; 2013 Aug; 12():114. PubMed ID: 23938193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma dipeptidyl-peptidase-4 activity is associated with left ventricular systolic function in patients with ST-segment elevation myocardial infarction.
    Li JW; Chen YD; Liu YQ; Wang JD; Chen WR; Zhang YQ; Ma Q
    Sci Rep; 2017 Jul; 7(1):6097. PubMed ID: 28733630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of plasma DPP4 activity in ST-elevation myocardial infarction.
    Li JW; Chen YD; Chen WR; You Q; Li B; Zhou H; Zhang Y; Han TW
    Cardiovasc Diabetol; 2017 Jun; 16(1):72. PubMed ID: 28587613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NT-proBNP, echocardiographic abnormalities and subclinical coronary artery disease in high risk type 2 diabetic patients.
    Reinhard H; Hansen PR; Wiinberg N; Kjær A; Petersen CL; Winther K; Parving HH; Rossing P; Jacobsen PK
    Cardiovasc Diabetol; 2012 Mar; 11():19. PubMed ID: 22390472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DPP4 Inhibition Ameliorates Cardiac Function by Blocking the Cleavage of HMGB1 in Diabetic Mice After Myocardial Infarction.
    Sato A; Suzuki S; Watanabe S; Shimizu T; Nakamura Y; Misaka T; Yokokawa T; Shishido T; Saitoh SI; Ishida T; Kubota I; Takeishi Y
    Int Heart J; 2017 Oct; 58(5):778-786. PubMed ID: 28966327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Greater circulating DPP4 activity is associated with impaired flow-mediated dilatation in adults with type 2 diabetes mellitus.
    Barchetta I; Ciccarelli G; Barone E; Cimini FA; Ceccarelli V; Bertoccini L; Sentinelli F; Tramutola A; Del Ben M; Angelico F; Baroni MG; Lenzi A; Cavallo MG
    Nutr Metab Cardiovasc Dis; 2019 Oct; 29(10):1087-1094. PubMed ID: 31431395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a definite diabetic cardiomyopathy in type 2 diabetes by comprehensive echocardiographic evaluation: A cross-sectional comparison with non-diabetic weight-matched controls.
    Ofstad AP; Urheim S; Dalen H; Orvik E; Birkeland KI; Gullestad L; W Fagerland M; Johansen OE; Aakhus S
    J Diabetes; 2015 Nov; 7(6):779-90. PubMed ID: 25350248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Interplay between Fasting Glucose, Echocardiography, and Biomarkers: Pathophysiological Considerations and Prognostic Implications.
    Pareek M
    Dan Med J; 2017 Sep; 64(9):. PubMed ID: 28874244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.
    David S; Kümpers P; Seidler V; Biertz F; Haller H; Fliser D
    Nephrol Dial Transplant; 2008 Apr; 23(4):1370-7. PubMed ID: 18089624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating dipeptidyl peptidase-4 activity is associated with insulin resistance in type 1 diabetic patients.
    Blaslov K; Bulum T; Duvnjak L
    J Diabetes Complications; 2015 Apr; 29(3):390-4. PubMed ID: 25641023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dipeptidyl peptidase-4 modulates left ventricular dysfunction in chronic heart failure via angiogenesis-dependent and -independent actions.
    Shigeta T; Aoyama M; Bando YK; Monji A; Mitsui T; Takatsu M; Cheng XW; Okumura T; Hirashiki A; Nagata K; Murohara T
    Circulation; 2012 Oct; 126(15):1838-51. PubMed ID: 23035207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The additive effects of type 2 diabetes mellitus on left ventricular deformation and myocardial perfusion in essential hypertension: a 3.0 T cardiac magnetic resonance study.
    Li XM; Jiang L; Guo YK; Ren Y; Han PL; Peng LQ; Shi R; Yan WF; Yang ZG
    Cardiovasc Diabetol; 2020 Sep; 19(1):161. PubMed ID: 32998742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular subclinical myocardial dysfunction in uncomplicated type 2 diabetes mellitus is associated with impaired myocardial perfusion: a contrast-enhanced cardiovascular magnetic resonance study.
    Liu X; Yang ZG; Gao Y; Xie LJ; Jiang L; Hu BY; Diao KY; Shi K; Xu HY; Shen MT; Ren Y; Guo YK
    Cardiovasc Diabetol; 2018 Oct; 17(1):139. PubMed ID: 30373588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of sitagliptin on the echocardiographic parameters of left ventricular diastolic function in patients with type 2 diabetes: a subgroup analysis of the PROLOGUE study.
    Yamada H; Tanaka A; Kusunose K; Amano R; Matsuhisa M; Daida H; Ito M; Tsutsui H; Nanasato M; Kamiya H; Bando YK; Odawara M; Yoshida H; Murohara T; Sata M; Node K;
    Cardiovasc Diabetol; 2017 May; 16(1):63. PubMed ID: 28490337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal pro B-type natriuretic peptide levels: correlation with echocardiographically determined left ventricular diastolic function in an ambulatory cohort.
    Dong SJ; de las Fuentes L; Brown AL; Waggoner AD; Ewald GA; Dávila-Román VG
    J Am Soc Echocardiogr; 2006 Aug; 19(8):1017-25. PubMed ID: 16880097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Plasma Dipeptidyl Peptidase-4 (DPP4) Activity Is an Obesity-Independent Parameter for Glycemic Deregulation in Type 2 Diabetes Patients.
    Sarkar J; Nargis T; Tantia O; Ghosh S; Chakrabarti P
    Front Endocrinol (Lausanne); 2019; 10():505. PubMed ID: 31402899
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes after myocardial infarction in mice.
    Sauvé M; Ban K; Momen MA; Zhou YQ; Henkelman RM; Husain M; Drucker DJ
    Diabetes; 2010 Apr; 59(4):1063-73. PubMed ID: 20097729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of midwall shortening reveals high prevalence of left ventricular myocardial dysfunction in patients with diabetes mellitus: the DYDA study.
    Cioffi G; Giorda CB; Chinali M; Di Lenarda A; Faggiano P; Lucci D; Maggioni AP; Masson S; Mureddu GF; Tarantini L; Velussi M; Comaschi M;
    Eur J Prev Cardiol; 2012 Oct; 19(5):935-43. PubMed ID: 21798988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of overweight on left ventricular function in type 2 diabetes mellitus.
    Suto M; Tanaka H; Mochizuki Y; Mukai J; Takada H; Soga F; Dokuni K; Hatani Y; Hatazawa K; Matsuzoe H; Sano H; Shimoura H; Ooka J; Matsumoto K; Hirota Y; Ogawa W; Hirata KI
    Cardiovasc Diabetol; 2017 Nov; 16(1):145. PubMed ID: 29121924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.